 |
 |
 |
 |
 |
 |
 |
 |
E-Mail
ShareHepatitis C Research
- Literature Citations for the Treatment of HIV/Hepatitis C Coinfection (Regularly Updated)
From U.S. National Institutes of Health - Literature Citations for the Incidence and Diagnosis of HIV/Hepatitis C Coinfection (Regularly Updated)
From U.S. National Institutes of Health - Hepatitis C Virus Infections Among HIV-Infected Men Who Have Sex With Men: An Expanding Epidemic (August 23, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Vertex: Telaprevir Could Shorten Hep C Treatment (August 11, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Tattoo Artists Need Closer Monitoring, Study Says (August 11, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Boomers May Be Last Boom of Hepatitis C (August 2, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - HCV SVR Rate Higher With Nevirapine Than Lopinavir in Multicenter Study (July 21, 2010)
From National AIDS Treatment Advocacy Project - HIV/HCV Coinfection Further Increases Risk of Bone Fractures (July 20, 2010)
From AIDSMeds.com - Viramune Boosts Hep C Treatment Efficacy in People With HIV (July 20, 2010)
From AIDSMeds.com - HCV in HIV-Positives Raises Osteoporotic Fracture Risk Over 40% (July 19, 2010)
From National AIDS Treatment Advocacy Project - Raltegravir in Hepatitis Co-Infection (June 30, 2010)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange - Looking Ahead: NIAID's Future HIV/AIDS Therapeutics Priorities (June 30, 2010)
From AIDS.gov - Impact of Hepatitis C Virus Coinfection on HAART in HIV-Infected Individuals: Multicentric Observation Cohort (June 7, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Evidence for the Effectiveness of Sterile Injecting Equipment Provision in Preventing Hepatitis C and Human Immunodeficiency Virus Transmission Among Injecting Drug Users: A Review of Reviews (May 4, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - HCV Survival in Syringes Affected by Syringe Type, Time and Temperature (March 3, 2010)
A discussion with Elijah Paintsil, M.D., F.A.A.P.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Successful Hepatitis C Treatment Reduces HIV Disease Progression and Non-Liver-Related Mortality (February 22, 2010)
From aidsmap.com - Chronic HIV and HCV Swell Stroke Risk in Veterans Aging Cohort (February 20, 2010)
From National AIDS Treatment Advocacy Project - Hepatitis C Virus Can Survive in Syringes for Up to 63 Days (February 20, 2010)
From aidsmap.com - Detachable Needles on Syringes Promote Hepatitis C Transmission, Study Says (February 19, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Meta-Analysis: Increased Mortality Associated With Hepatitis C in HIV-Infected Persons Is Unrelated to HIV Disease Progression (January 13, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Researchers Find Genetic Explanation for Why Hepatitis C (HCV) Treatment Doesn't Work for Some (January 6, 2010)
From The Body - Sexual Transmission of Hepatitis C Happens Through Blood, Not Semen, in Gay Men With HIV, Study Says (November 17, 2009)
From The Body - U.S.: 1 in 12 Truckers Has Hepatitis C (November 12, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - A Few Coffees a Day Keep Liver Disease at Bay: Study (October 26, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Risk of Developing Specific AIDS-Defining Illnesses in Patients Co-Infected With HIV and Hepatitis C Virus With or Without Liver Cirrhosis (October 5, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Men's Sex Lives May Suffer on Hepatitis C Therapy (September 22, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Both Hepatitis C Drugs Work About the Same: Study (August 11, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Sustained Response to Interferon Improves Fibrosis in HIV/HCV-Coinfected Patients (July 23, 2009)
HIV-infected people who achieve a sustained virological response to hepatitis C treatment using pegylated interferon plus ribavirin may experience regression of fibrosis and even cirrhosis, according to study findings.
From aidsmap.com - Study Confirms International Outbreak of Sexually Transmitted Hep C (June 5, 2009)
In CATIE News, from Canadian AIDS Treatment Information Exchange - Hepatitis C Transmission Among HIV-Infected Men Who Have Sex With Men Is Occurring Primarily in Men Older Than 35 (February 11, 2009)
An interview with Sarah Fishman.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Hepatitis C Ups Liver Cancer Risk, Study Confirms (January 20, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Hepatitis C Coinfection May Increases Heart Attack, Stroke Risk, Study Finds (August 12, 2008)
In aidsmap.com - New Theory Suggests How Hepatitis C May Cause Rare Immune Disease (May 9, 2008)
From Rockefeller University - Hepatitis C: New Treatments in the Pipeline (April 2008)
To read PDF, click here.
From Treatment Action Group - CROI: Choice of Nucleoside Analogue in Co-Infection: Tenofovir Associated With Better Response to HCV Therapy (February 15, 2008)
From aidsmap.com - Study Examines Pro-Inflammatory Responses in HIV/HCV-Coinfected Injection Drug Users (February 6, 2008)
From The Body PRO - HIV/Hepatitis C Coinfection Does Not Influence CD4+ Cell Recovery in Patients on Suppressive HAART (February 5, 2008)
Lars Peters, M.D., discusses his study, which counters long-established assumptions about the effect of HCV/HIV coinfection on immune recovery after patients commence antiretroviral therapy.
From The Body PRO - HIV/HCV-Coinfected Patients Appear More Likely Than HIV-Monoinfected Patients to Develop Insulin Resistance After Initiating HAART (February 5, 2008)
From The Body PRO - Higher HCV RNA Levels Associated With Greater Early T-Cell Activation and CD4+ Cell Depletion Among Antiretroviral-Naive, HIV/HCV-Coinfected Patients (February 5, 2008)
From The Body PRO - Rapid Liver Fibrosis Occurring More Frequently Among HIV-Infected Men Newly Coinfected With Hepatitis C (February 4, 2008)
An interview with Daniel Fierer, M.D.
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Daily Cannabis Use Associated With Worse Fibrosis in Patients With Chronic Hepatitis C (January 29, 2008)
From aidsmap.com - CD4 Cell Count Is No Predictor of Hepatitis C Treatment Success (January 18, 2008)
From aidsmap.com - First Large Head-to-Head Comparison of Schering and Roche HCV Therapies: Similar Virologic Responses; Fewer Relapses With PegIntron (January 16, 2008)
From aidsmap.com - EACS: Studies Underline the Need for Better Hepatitis C Treatment (November 2, 2007)
From aidsmap.com - Undetectable Viral Load Is Goal for All, Together With Earlier Treatment, Say New European Treatment Guidelines (October 25, 2007)
From aidsmap.com - News From the Front (Fall 2007)
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America - Routine Hepatitis C Screening Urged for Patients Diagnosed With HIV: Study (September 27, 2007)
In aidsmap.com - Testing Method Could Predict Sustained Virologic Response to HCV Treatment at Four Weeks (August 15, 2007)
From Reuters Health - Rapid and Early Virological Response to Chronic Hepatitis C Treatment With IFN Alpha-2b or PEG-IFN Alpha-2b Plus Ribavirin in HIV/HCV Coinfected Patients (August 2007)
In Gut - SMART Substudy on Hepatitis Coinfection (July 24, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO - Hepatitis C Treatment (July 23, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO - Sexual Transmission of Hepatitis C (July 23, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO - Early HCV Treatment Is Usually Successful in HIV/HCV-Coinfected Gay Men (July 11, 2007)
From aidsmap.com - Study May Disprove Link Between HIV/Hep C Coinfection and Some Metabolic Problems (May 21, 2007)
A pair of new U.S. studies appears to contradict long-held concerns that HIV/hepatitis C-coinfected people have a higher risk of diabetes and lipoatrophy (fat loss).
From aidsmap.com - Acute Hepatitis C Infection in HIV-Infected Men: An Emerging Epidemic (May 2007)
A detailed discussion by Mark Danta, M.D., M.P.H., of the University of New South Wales Australia.
In The PRN Notebook - HCV Relapse Common, Treatment Success Uncertain Following Liver Transplant in HIV/HCV-Coinfected Patients (January 12, 2007)
From aidsmap.com - Cardiovascular Disease Risk Higher Among HIV/HCV-Coinfected Patients (January 11, 2007)
In AIDS - Lipid Abnormalities in HIV/Hepatitis C Virus-Coinfected Patients (November 2006)
In HIV Medicine - redirect --> http://www.washingtonpost.com/wp-dyn/content/article/2006/09/12/AR2006091201444.html (September 13, 2006)
In The Washington Post - HIV/HCV Coinfection Exacerbates ESLD Risk (September 2006)
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Advocacy Groups Charge Schering-Plough With Racial Discrimination for Excluding Blacks From Hepatitis C Trial (April 3, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Chronic Hepatitis C in the Hispanic Population (March 2006)
To read PDF, click here.
From HCV Advocate - Literature Review: Hospitalizations, Expenditures Due to Hepatitis C on the Rise in U.S. (January 2006)
In Infectious Diseases in Corrections Report, from Brown Medical School - Mother-to-Child Hepatitis C Transmission Twice as Likely Among Infant Girls as Boys (December 19, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Ritonavir-Boosted Tipranavir Increases ALT and AST Levels in HIV/Hepatitis-Coinfected Patients (December 16, 2005)
[Archived Article]
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy - Many Infants Acquire Hepatitis C Infection From Infected Mothers in Utero (September 7, 2005)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Study Finds Epoetin Alfa Improves Anemia in HIV/HCV-Coinfected Patients (August 2005)
[Archived Article]
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Fosamprenavir + Ritonavir Appears Safe Through 120 Weeks in HIV/HBV and HIV/HCV-Coinfected Patients (July 26, 2005)
[Archived Article]
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment - Adverse Event Risk on Abacavir + Lamivudine Is Not Higher for Patients Coinfected With Hepatitis B and/or Hepatitis C (July 26, 2005)
[Archived Article]
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment - HIV and Hepatitis C Coinfection: No Increase in HIV Disease Progression (April 2005)
[Archived Article]
Results from a rather large U.S. study comprised mostly of young women of color.
From The Body PRO - Barriers to Care of HCV for Drug Users: Access Not the Only Problem, Study Suggests (January 2005)
[Archived Article]
In Infectious Diseases in Corrections Report, from Brown Medical School - HCV Therapy in Coinfected Patients: The Rise of Peginterferon Alfa-2a (January 2005)
[Archived Article]
Part of HIV JournalView's Top 10 Research Reports of 2004.
From The Body PRO - Hepatitis C Clearance Examined in Injection Drug Users (December 2004)
[Archived Article]
In Infectious Diseases in Corrections Report, from Brown Medical School - Long-Term Outcome Looks Good for Chronic Hepatitis C Patients Receiving Successful Treatment (December 2004)
[Archived Article]
In Infectious Diseases in Corrections Report, from Brown Medical School - IDSA Conference Highlights: Hepatitis C Mono/Coinfection Seminar (December 2004)
[Archived Article]
To read PDF, click here.
In Infectious Diseases in Corrections Report, from Brown Medical School - Coinfection With Hepatitis C May Shorten Lives of HIV-Infected People (November 10, 2004)
[Archived Article]
Among a cohort of 970 HIV-infected U.S. veterans, those with hepatitis C faced a greater risk of death and were less likely to receive HAART.
From aidsmap.com - High Rate of Relapse Found in HIV/HCV-Coinfected Patients (October 2004)
[Archived Article]
Quick recap of a study in the journal AIDS Research and Human Retroviruses.
In HIV Treatment ALERTS!, from The Center for AIDS - HIV JournalView: HCV as a Rationale for C-Section in HIV-Infected Pregnant Women (October 2004)
[Archived Article]
From The Body PRO - New Hepatitis C Combo Regimen May Cause Serious Eye Problems (August 26, 2004)
[Archived Article]
Regular ophthalmologic exams are recommended for HIV/hepatitis C-coinfected patients taking peginterferon alfa-2b (PEG-Intron) and ribavirin.
From aidsmap.com - Both Tenofovir and Stavudine Well Tolerated in HCV-Coinfected Patients (July 12, 2004)
[Archived Article]
In The XV International AIDS Conference, from The Body PRO - Response to Lopinavir/Ritonavir in HIV-Infected Patients Coinfected With Hepatitis C and/or Hepatitis B (July 12, 2004)
[Archived Article]
In The XV International AIDS Conference, from The Body PRO - PegIFN/Ribavirin During Acute HCV Coinfection (July 2004)
[Archived Article]
If tolerated, combination hepatitis C therapy used during the first six months of infection can lead to a high rate of viral clearance in patients coinfected with HIV.
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Hepatitis C Treatment Regimen Far Less Successful Among Black Patients (June 1, 2004)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - The 39th European Association for the Study of the Liver (April 18, 2004)
[Archived Article]
Browse through the abstracts from this annual meeting.
- CROI 2004 Recap: HIV, HCV and HBV (April 2004)
[Archived Article]
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Results of Three Large HCV Treatment Trials Presented at XI CROI (April 2004)
[Archived Article]
In TAGline, from Treatment Action Group - HCV and Neuropsychological Impairment (April 2004)
[Archived Article]
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Neopterin a Novel Marker of Immune Function in Hepatitis C (March 2004)
[Archived Article]
To read PDF, click here.
From HCV Advocate - Hepatitis C Coinfection Review (March/April 2004)
[Archived Article]
An overview of the newest treatments and studies.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network - Peginterferon Alfa-2a Plus Ribavirin Found Superior to Peginterferon Alfa-2a Monotherapy and Interferon Plus Ribavirin (February 23, 2004)
[Archived Article]
From HIV InSite - Liver Transplants Safe, Successful in Otherwise Healthy HIV Patients (February 11, 2004)
[Archived Article]
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Nelfinavir, Lopinavir/Ritonavir Appear Safe for Hepatitis C Patients (February 10, 2004)
[Archived Article]
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Hepatitis C May Negatively Impact Neurocognitive Function (February 9, 2004)
[Archived Article]
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - HCV Snapshots: Macro to Micro (October 2003)
[Archived Article]
HIV/hepatitis C coinfection research from the 9th European AIDS Conference.
In GMHC Treatment Issues, from Gay Men's Health Crisis - 18 Months of HCV Therapy Needed to Prevent High Relapse Rate, Study Finds (September 16, 2003)
[Archived Article]
From aidsmap.com - HCV Coinfection Associated With an Increased Risk of Diabetes in HIV-Positive U.S. Veterans (September 16, 2003)
[Archived Article]
From aidsmap.com - Saliva May Have Infectious Amounts of HCV in Presence of High HCV Viral Load and Gum Disease (September 16, 2003)
[Archived Article]
From aidsmap.com - Peg-IFN Achieves Poor Results in HIV-HCV Patients Even When Used With Ribavirin (September 15, 2003)
[Archived Article]
From aidsmap.com - HAART Often Successful in HIV/HCV Coinfected Patients -- If They Can Stay on Treatment (September 15, 2003)
[Archived Article]
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO - Thymalfasin May Help HCV Patients Who Have Failed Treatment (September 10, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Hepatitis C Found to Diminish Response to HAART (August 12, 2003)
[Archived Article]
From Canadian AIDS Treatment Information Exchange - Hepatitis C and Cognitive Impairment (August 2003)
[Archived Article]
To read PDF, click here.
From HCV Advocate - Ribapharm Loses Ruling on Hepatitis C Drug; Finding Allows Generic Competition for Ribavirin (July 18, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Report Questions Early Treatment of Hepatitis C (July 9, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Sniffing/Sorting Cocaine and Heroin May Add to Hepatitis C Risk (July 9, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Pretreatment of Chronic Active Hepatitis C in Patients Coinfected With HIV and Hepatitis C Virus Reduces the Hepatotoxicity Associated With Subsequent Antiretroviral Therapy (June 1, 2003)
[Archived Article]
A study suggests that receiving hepatitis C treatment before starting HAART, rather than after, can help reduce liver damage.
In Journal of AIDS - Latinos and Hepatitis C (June 2003)
[Archived Article]
To read PDF, click here.
From HCV Advocate - First Clinical Care Options for Hepatitis, June 19-22 (May 30, 2003)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News - Asian Americans at High Risk for Hepatitis C Liver Cancer (May 23, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Liver Damage a Concern for HAART Patients With Hepatitis C, Low CD4 (May 1, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Theory Links Hepatitis C to Polio Syringes in Italy (April 30, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Experimental Drugs Block Hepatitis C Virus (April 25, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Genotype, Enzyme Levels, and Viral Load Are Clues to Hepatitis C Virus Outcomes (April 11, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Hepatitis C and Fatigue (April 2003)
[Archived Article]
To read PDF, click here.
From HCV Advocate - Case Study: 36-Year-Old Male With Hepatitis C and HIV Infection (April 2003)
[Archived Article]
To read PDF, click here.
In HEPP Report, from Brown Medical School - Developing a Systematic Approach to Hepatitis C for Correctional Systems: Controversies and Emerging Consensus (April 2003)
[Archived Article]
To read PDF, click here.
In HEPP Report, from Brown Medical School - High-Dose Interferon Effective in Patients Coinfected With Hepatitis C (March 12, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Influence of Coinfection With Hepatitis C Virus on Morbidity and Mortality Due to Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy (February 2003)
[Archived Article]
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Research and Policy Recommendations for HCV/HIV Coinfection (February 2003)
[Archived Article]
To read PDF, click here.
In TAGline, from Treatment Action Group - Is Hepatitis C Virus Going to Become a Major STD? (December 18, 2002)
[Archived Article]
From Canadian AIDS Treatment Information Exchange - Bleaching Needles May Help Protect Against Hep C (November 20, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - New York Veterans Suffer High Rates of Hepatitis C With HIV Infection (November 6, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - The Role of the Immune System in Determining Viral Outcome After Hepatitis C Viral (HCV) Infection (November 2002)
[Archived Article]
To read PDF, click here.
From HCV Advocate - Hepatitis C May Not Progress as Often as Believed (November 1, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Hepatitis Worse During Immunocompetence With HIV/Hepatitis C Coinfection (October 9, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - HCV Infection Doesn't Reduce High-Risk Activities in Injection-Drug Users (October 3, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Study: Hepatitis Shots Show Promise (September 26, 2002)
[Archived Article]
In a recent study, peginterferon alfa-2a plus ribavirin beats the standard hepatitis C treatment.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Hepatitis C Screening and Management Practices: A Survey of Drug Treatment and Syringe Exchange Programs in New York City (August 13, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Hepatitis C in Vietnam Era Veterans (August 2002)
[Archived Article]
To read PDF, click here.
From HCV Advocate - HIV-Protective Gene May Boost Hepatitis C Infection (July 26, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Some HIV-Positive People at Greater Risk for Liver Problems (July 24, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Chronic Hepatitis C in the Veteran Population (June 2002)
[Archived Article]
To read PDF, click here.
From HCV Advocate - High Hepatitis C Rates in San Francisco Bay Area; University of California Study Finds Possible Links to Herpes, Cocaine Use (April 2, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - A New Look at Liver Toxicity Development During Antiretroviral Therapy Containing Protease Inhibitors in Patients With HIV (March 11, 2002)
[Archived Article]
To read PDF, click here.
In STEP Ezine, from Seattle Treatment Education Project - The Role of Antiviral Therapy in the Natural History of Hepatitis C Fibrosis (February 2002)
[Archived Article]
To read PDF, click here.
From HCV Advocate - Pancreatitis: An Emerging Complication of HCV Treatment in HIV Co-Infected Patients Treated With Didanosine/Stavudine Containing Regimens (December 17, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Evaluation of Two Doses of Peginterferon Alfa-2a for the Treatment of Chronic Hepatitis C (CHC) (December 16, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Pathogenesis of Hepatitis C Virus (HCV) in HIV-Positive Patients (December 16, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Anemia Symposium Discusses Relationship With HIV, Cancer, Hepatitis C; Discusses Erythropoietin Use (December 16, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Effect of HAART on Liver-Related Mortality in HIV/HCV Co-Infected Patients (November 12, 2001)
[Archived Article]
In 52nd Annual Meeting of the American Association for the Study of Liver Diseases, from The Body PRO - Early Prediction of Response to 40 kda Peginterferon alfa-2A (Pegasys) Plus Ribavirin in Patients With Chronic Hepatitis C (November 12, 2001)
[Archived Article]
In 52nd Annual Meeting of the American Association for the Study of Liver Diseases, from The Body PRO - The Clinical Significance of Hepatitis C Virus (HCV) in Human Immunodeficiency Virus (HIV) Co-Infection (November 12, 2001)
[Archived Article]
In 52nd Annual Meeting of the American Association for the Study of Liver Diseases, from The Body PRO - Treatment With 40KDA Peginterferon Alfa-2a (Pegasys) in Combination With Ribavirin Significantly Enhances Quality of Life Compared With Interferon Alfa-2b Plus Ribavirin (November 11, 2001)
[Archived Article]
In 52nd Annual Meeting of the American Association for the Study of Liver Diseases, from The Body PRO - Analysis of 40KDA Peginterferon Alfa-2a (Pegasys) in Combination With Ribavirin, Mycophenolate Mofetil, Amantadine or Amantadine Plus Ribavirin in Patients That Relapsed or Did Not Respond to Rebetron Therapy: A Report of Two Randomized Mulitcenter Effica (November 11, 2001)
[Archived Article]
In 52nd Annual Meeting of the American Association for the Study of Liver Diseases, from The Body PRO - HIV and HCV Co-Infection -- Current Status and Future Directions (October 27, 2001)
[Archived Article]
In 39th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO - Retrospective Review of Nevirapine-Induced Hepatotoxicity in HIV/HCV Co-Infected Patients in a Community Health Center (October 27, 2001)
[Archived Article]
In 39th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO - HCV: PEG-Interferons -- When to Use Them (October 23, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO - Novel Treatments for HCV (October 21, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO - Giving Interferon Early: An Improved HCV Treatment? (October 2001)
[Archived Article]
In HEPP News, from Brown Medical School - Liver Fibrosis in HIV/Hepatitis C Coinfection: HIV Protease Inhibitors May Be Protective (August 24, 2001)
[Archived Article]
To read PDF, click here.
In AIDS Treatment News, from AIDS Treatment News - New Peg-Interferon Results (August 2001)
[Archived Article]
To read PDF, click here.
In Project Inform Perspective, from Project Inform - Pegylated Interferon Plus Ribavirin for the Treatment of Chronic Hepatitis C in HIV-Infected Patients (July 9, 2001)
[Archived Article]
In The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO - Non-Injection Drug Users at Risk for HCV (June/July 2001)
[Archived Article]
In HEPP News, from Brown Medical School - Liver Transplants Successful in HIV-Positive People (Summer/Autumn 2001)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - Two Cases of Fatal and Severe Hepatitis Associated With RIF and PZA (May 2001)
[Archived Article]
In HEPP News, from Brown Medical School - Does HCV Negatively Impact on HIV Disease Progression and Survival? (April 2001)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis - Hepatitis C (HCV) Co-Infection Is Associated With Increased Morbidity and Mortality Among HIV-Infected Patients (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - HCV Co-Infection and Summary Session (State-of-the-Art Lecture) (February 5, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.